UBS Group’s Barington/Hilco Acquisition Corp. Units BHACU Stock Holding History

UBS Group’s Portfolio BHACU Stock Details BHACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,255	Closed	-$13K	–	8654
2018 Q3	$13K	Hold	1,255	–	–	﹤0.01%	7052
2018 Q2	$14K	Buy	+1,255	New	+$20.5K	﹤0.01%	6966

UBS Group's BHACU Position: Q4 2018 in Review

UBS Group sold out of Barington/Hilco Acquisition Corp. Units (BHACU) in Q4 2018, closing a stake of 1,255 shares — an estimated $13K sold.

UBS Group first reported a position in BHACU in Q2 2018 and held it in 2 quarters. The position peaked at $14K in Q2 2018. 0 funds tracked by Wall St. Rank hold BHACU as of Q4 2018.

UBS Group reported no remaining Barington/Hilco Acquisition Corp. Units position as of Q4 2018 after selling out during the quarter.
UBS Group sold 1,255 Barington/Hilco Acquisition Corp. Units shares in Q4 2018, an estimated $13K.
UBS Group first reported a position in Barington/Hilco Acquisition Corp. Units in Q2 2018 and held it in 2 quarters.
UBS Group's Barington/Hilco Acquisition Corp. Units position peaked at $14K in Q2 2018.
0 funds tracked by Wall St. Rank held Barington/Hilco Acquisition Corp. Units as of Q4 2018.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.